Respiratory training with a specific device in cystic fibrosis: A prospective study

R. Sartori, E. Barbi, F. Poli, L. Ronfani, F. Marchetti, A. Amaddeo, A. Ventura

Research output: Contribution to journalArticle

Abstract

Introduction: Chest physiotherapy (CP) is used in cystic fibrosis (CF) even if there is no robust scientific evidence of a beneficial effect. We investigated the effects of a training with a specific device (SpiroTiger®) in a group of CF patients. This device, developed for respiratory training through maximal inspirations and espirations without hypocarbia, may improve respiratory function and mucus clearance. Patients where instructed and trained by a physiotherapist with individualized settings of training parameters. Methods: Twenty-four patients were enrolled in an open-label 1 year observational study. Baseline and post intervention measurements were determined by lung function (FVC, FEV1, FEF 25-75), patients' opinions on physiotherapy (questionnaires), need for antibiotic treatment (clinical follow-up and records) and perception of physical fitness (questionnaires) in the year before and in the year of intervention. Adherence to physiotherapy was monitored by means of a specific device software. Results: Increased lung function (FEV1 p <0.01), perception of physical fitness (p <0.001) and a reduction in the need for intravenous antibiotic treatment (p <0.001) were reported. Adherence to treatment was good/acceptable in 92% of patients. Conclusions: This study shows an association between training through a specific device and improved lung function. Further trials are needed to confirm this report.

Original languageEnglish
Pages (from-to)313-319
Number of pages7
JournalJournal of Cystic Fibrosis
Volume7
Issue number4
DOIs
Publication statusPublished - Jul 2008

Keywords

  • Antibiotic treatment
  • Lung function
  • Respiratory training
  • SpiroTiger®

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Respiratory training with a specific device in cystic fibrosis: A prospective study'. Together they form a unique fingerprint.

  • Cite this